SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 34.37 |
| Enterprise Value ($M) | 14.44 |
| Book Value ($M) | 52.09 |
| Book Value / Share | 3.53 |
| Price / Book | 0.66 |
| NCAV ($M) | 49.62 |
| NCAV / Share | 3.36 |
| Price / NCAV | 0.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.76 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.35 |
| Current Ratio | 4.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 64.44 |
| Assets | 66.91 |
| Liabilities | 14.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.50 |
| Operating Income | -43.64 |
| Net Income | -39.83 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Soleus Capital Master Fund, L.P. | 0.00 | -100.00 | |
| 13G/A | Citadel Advisors Llc | 8.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 913 | 43,819 | 2.08 | |
| 628 | 8,752 | 7.18 | |
| 5,600 | 37,537 | 14.92 | |
| 796 | 36,801 | 2.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VTGN – Vistagen Therapeutics, Inc. | VTVT – vTv Therapeutics Inc. |
| VXRT – Vaxart, Inc. | WINT – Windtree Therapeutics, Inc. |
| XBIO – Xenetic Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io